ColgatePalmolive (CL)
(Delayed Data from NYSE)
$96.49 USD
-0.11 (-0.11%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $96.50 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$96.49 USD
-0.11 (-0.11%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $96.50 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth C Momentum B VGM
Zacks News
Here's How Colgate (CL) Looks Ahead of Q3 Earnings Report
by Zacks Equity Research
Colgate's (CL) Q3 performance is expected to have benefited from strong demand for essential goods, robust e-commerce sales and a booming pet business despite higher costs and currency.
Why Colgate-Palmolive (CL) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Colgate-Palmolive (CL) have what it takes? Let's find out.
Earnings Preview: Colgate-Palmolive (CL) Q3 Earnings Expected to Decline
by Zacks Equity Research
Colgate-Palmolive (CL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Colgate-Palmolive (CL) Upgraded to Buy: Here's Why
by Zacks Equity Research
Colgate-Palmolive (CL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Is ColgatePalmolive (CL) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Is (CL) Outperforming Other Consumer Staples Stocks This Year?
This is Why Colgate-Palmolive (CL) is a Great Dividend Stock
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Colgate-Palmolive (CL) have what it takes? Let's find out.
Coronavirus-Led Pet Boom Puts the Spotlight on These 7 Stocks
by Payel Dhar
As people are largely staying indoors due to the COVID-19 situation, they have taken to pets to fight emotional stress
Colgate Up More Than 10% YTD on Demand: Will It Move Higher?
by Zacks Equity Research
Colgate (CL) remains well placed with strong product demand, robust pricing efforts and sturdy online show, which are boosting organic sales. However, costs and currency-related headwinds persist.
Why Colgate-Palmolive (CL) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Colgate-Palmolive (CL) have what it takes? Let's find out.
5 Industry ETFs Set to Beat Slowing Retail Sales
by Sanghamitra Saha
Retail sales in the United States increased 0.6% sequentially in August 2020, following a downwardly revised 0.9% rise in July.
Church & Dwight (CHD) Gains on High Demand & Online Strength
by Zacks Equity Research
Church & Dwight (CHD) has been gaining from rising demand for essential items amid the pandemic. The company's online business is likely to perform well, thanks to social distancing trends.
Retirees Should Know These 3 Facts About Required Minimum Distributions - September 14, 2020
by Zacks Equity Research
Like many investors, you're likely aiming to build a comfortable nest egg to ensure a comfortable retirement. Make sure you know all about what financial planners dub the accumulation and distribution phases of retirement planning.
The Zacks Analyst Blog Highlights: TSLA, MA, UPS, SQ and CL
by Zacks Equity Research
The Zacks Analyst Blog Highlights: TSLA, MA, UPS, SQ and CL
This is Why Colgate-Palmolive (CL) is a Great Dividend Stock
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Colgate-Palmolive (CL) have what it takes? Let's find out.
The Earnings Big Picture & Analyst Reports for Tesla, Mastercard & Others
by Sheraz Mian
Today's Research Daily features an update on the overall earnings picture, in addition to new research reports on Tesla (TSLA), Mastercard (MA) and UPS (UPS).
Why Is Colgate-Palmolive (CL) Up 3.3% Since Last Earnings Report?
by Zacks Equity Research
Colgate-Palmolive (CL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Colgate-Palmolive (CL) Moves to Buy: Rationale Behind the Upgrade
by Zacks Equity Research
Colgate-Palmolive (CL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Is ColgatePalmolive (CL) Outperforming Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Is (CL) Outperforming Other Consumer Staples Stocks This Year?
Why Colgate-Palmolive (CL) Stock Might be a Great Pick
by Zacks Equity Research
Colgate-Palmolive (CL) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
This is Why Colgate-Palmolive (CL) is a Great Dividend Stock
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Colgate-Palmolive (CL) have what it takes? Let's find out.
Church & Dwight Gains 30% in 3 Months on Pandemic-Led Demand
by Zacks Equity Research
Church & Dwight (CHD) gains on robust demand for household and personal care products amid the pandemic. High costs are a worry.
Colgate's Sales Gain on Strong Demand Amid Currency Woes
by Zacks Equity Research
Colgate (CL) remains well placed with strong product demand, robust pricing efforts and sturdy online show, which are boosting organic sales. However, cost and currency-related headwinds continue.
Looking for a Growth Stock? 3 Reasons Why Colgate-Palmolive (CL) is a Solid Choice
by Zacks Equity Research
Colgate-Palmolive (CL) could produce exceptional returns because of its solid growth attributes.
The Zacks Analyst Blog Highlights: Amazon, Visa, United Parcel Service, Lockheed Martin and Colgate-Palmolive
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Amazon, Visa, United Parcel Service, Lockheed Martin and Colgate-Palmolive
Are You Looking for a High-Growth Dividend Stock? Colgate-Palmolive (CL) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Colgate-Palmolive (CL) have what it takes? Let's find out.